-

06:57:32 AM

Latest TECH Stock Market News

TECH - Bio-Techne Corp

09/14/21 7:00 AM

Nasdaq : TECH

Bio-Techne Launches ExCellerate™ iPSC Expansion Medium

Bio-Techne Corporation (NASDAQ: TECH) Bio-Techne announced the launch of a new medium for the expansion and maintenance of induced pluripotent stem cells (iPSCs) for use in both research and translational workflows. The ExCellerate™ iPSC Expansion Medium

RHEA-AI

neutral

09/08/21 7:00 AM

Nasdaq : TECH

clinical trialcovid-19

Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis

Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and

RHEA-AI

positive

09/02/21 7:00 AM

Nasdaq : TECH

conferences

Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 2:00 p.m. EDT. A live webcast of the

RHEA-AI

neutral

08/05/21 6:30 AM

Nasdaq : TECH

dividends

Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2021. The quarterly dividend will be payable August 27, 2021 to all common shareholders of record on

RHEA-AI

neutral

08/05/21 6:30 AM

Nasdaq : TECH

earnings

Bio-Techne Releases Fourth Quarter Fiscal 2021 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021.Fourth Quarter FY2021 SnapshotFourth quarter organic revenue increased by 39% (47% reported) to $259.0 million. Full year organic growth

RHEA-AI

neutral

08/04/21 7:00 AM

Nasdaq : TECH

covid-19

Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2

Bio-Techne Corporation (NASDAQ: TECH) today announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC) recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection and

RHEA-AI

neutral

08/03/21 7:00 AM

Nasdaq : TECH

Bio-Techne Announces 2021 Investor Day and Webcast

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York

RHEA-AI

neutral

07/28/21 7:00 AM

Nasdaq : TECH

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 total capsid quantification. Bio-Techne, owner of the leading ProteinSimple branded protein analysis

RHEA-AI

neutral

07/27/21 7:00 AM

Nasdaq : TECH

Bio-Techne Announces Commercial Release of RNAscope™ HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and Fresh Frozen Samples.

Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ hybridization technology portfolio with the release of new RNAscope HiPlex V2 assay for formalin-fixed

RHEA-AI

neutral

07/13/21 7:00 AM

Nasdaq : TECH

conferencesearnings

Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, August 5, 2021, at 8:00 a.m. CDT to review fourth quarter 2021 financial results.Access to the discussion may be obtained as

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 Next